SLU-PP-332 – 500 mcg Capsules

SLU-PP-332 – 500 mcg Capsules

SLU-PP-332 is a novel research compound currently under investigation for its potential role in mitochondrial function, metabolic regulation, and energy expenditure pathways. Preclinical research has focused on its activity as an estrogen-related receptor (ERR) agonist, a pathway closely associated with oxidative metabolism, endurance signalling, and cellular energy utilisation.

This formulation is supplied as 500 mcg oral Capsule, offering precise and consistent dosing for controlled research environments where accuracy and repeatability are essential.

Primary Research Areas

• Mitochondrial biogenesis and function

• Metabolic rate and energy expenditure pathways

• Exercise-mimetic and endurance-related signalling

• Cellular oxidative metabolism and fuel utilisation

Product Specifications

• Compound: SLU-PP-332

• Dosage Form: Oral tablets

• Strength: 500 mcg per tablet

• Grade: Research use only

• Packaging: Laboratory-style sealed container

AussieBio Labs Quality Commitment

• Research-grade compounds

• Batch-controlled production

• Designed for laboratory and investigative use

• Clean, professional packaging suitable for research settings